FR2351112A1 - Derive de prostaglandine et medicament contenant ce derive - Google Patents

Derive de prostaglandine et medicament contenant ce derive

Info

Publication number
FR2351112A1
FR2351112A1 FR7714201A FR7714201A FR2351112A1 FR 2351112 A1 FR2351112 A1 FR 2351112A1 FR 7714201 A FR7714201 A FR 7714201A FR 7714201 A FR7714201 A FR 7714201A FR 2351112 A1 FR2351112 A1 FR 2351112A1
Authority
FR
France
Prior art keywords
cpds
healing
alpha
derivs
prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7714201A
Other languages
English (en)
French (fr)
Other versions
FR2351112B1 (enrdf_load_stackoverflow
Inventor
Salvador Moncada
Norman Whittake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/624,486 external-priority patent/US3984400A/en
Priority claimed from FR7631769A external-priority patent/FR2361871A1/fr
Priority claimed from FR7710593A external-priority patent/FR2351111A1/fr
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2351112A1 publication Critical patent/FR2351112A1/fr
Application granted granted Critical
Publication of FR2351112B1 publication Critical patent/FR2351112B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7714201A 1975-10-21 1977-05-10 Derive de prostaglandine et medicament contenant ce derive Granted FR2351112A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/624,486 US3984400A (en) 1975-10-21 1975-10-21 11-Desoxy-16-aryl-ω-tetranorprostaglandins
FR7631769A FR2361871A1 (fr) 1975-10-21 1976-10-21 11-desoxy-16-arylprostaglandines 13-acetyleniques
FR7710593A FR2351111A1 (fr) 1976-05-11 1977-04-07 Methylacetals de 2-(2b-ethynyl-cyclopent-1a-yl) acetaldehydes et leur preparation

Publications (2)

Publication Number Publication Date
FR2351112A1 true FR2351112A1 (fr) 1977-12-09
FR2351112B1 FR2351112B1 (enrdf_load_stackoverflow) 1981-05-29

Family

ID=27250686

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7714201A Granted FR2351112A1 (fr) 1975-10-21 1977-05-10 Derive de prostaglandine et medicament contenant ce derive

Country Status (1)

Country Link
FR (1) FR2351112A1 (enrdf_load_stackoverflow)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2359125A1 (fr) * 1976-02-04 1978-02-17 Upjohn Co Nouveaux derives de prostaglandine, leur procede de preparation et medicament les contenant
FR2378777A1 (fr) * 1977-01-31 1978-08-25 Ono Pharmaceutical Co Nouveaux analogues de prostaglandines
FR2401141A1 (fr) * 1977-03-07 1979-03-23 Upjohn Co Nouveaux derives halogenes de prostaglandines et medicaments les contenant
FR2401921A1 (fr) * 1977-07-28 1979-03-30 Upjohn Co Derives de prostaglandines
EP0001270A1 (de) * 1977-09-27 1979-04-04 Hoechst Aktiengesellschaft Neue Prostacyclin-Analoga, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Behandlung von Herzkreislauf-Krankheiten
EP0005768A1 (en) * 1978-05-17 1979-12-12 The Wellcome Foundation Limited Pharmaceutical formulations containing prostaglandin compounds and method for their preparation
EP0013955A1 (de) * 1979-01-25 1980-08-06 Hoechst Aktiengesellschaft Neue Analoga von Prostacyclin, deren Zwischenprodukte, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
EP0052204A1 (en) * 1980-11-13 1982-05-26 American Cyanamid Company Prostacyclin analogs of the 1 series and related analogs
FR2513639A1 (fr) * 1981-09-25 1983-04-01 Squibb & Sons Inc Nouvelles prostacyclines dioxatricycliques utiles comme medicaments cardio-vasculaires et produits nouveaux utiles comme intermediaires pour leur synthese
EP0084775A1 (de) * 1982-01-21 1983-08-03 MERCK PATENT GmbH 13-Thia-Prostacycline
WO2013024051A1 (en) * 2011-08-12 2013-02-21 Ascendis Pharma A/S Sustained release composition of prostacyclin
CN116621852A (zh) * 2023-04-21 2023-08-22 大连理工大学 基于内过氧化物的抗凝剂及应用

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2359125A1 (fr) * 1976-02-04 1978-02-17 Upjohn Co Nouveaux derives de prostaglandine, leur procede de preparation et medicament les contenant
FR2362833A1 (fr) * 1976-02-04 1978-03-24 Upjohn Co Nouveaux derives 5 de prostaglandine, leur procede de preparation et medicament les contenant
FR2378777A1 (fr) * 1977-01-31 1978-08-25 Ono Pharmaceutical Co Nouveaux analogues de prostaglandines
FR2401141A1 (fr) * 1977-03-07 1979-03-23 Upjohn Co Nouveaux derives halogenes de prostaglandines et medicaments les contenant
FR2401139A2 (fr) * 1977-03-07 1979-03-23 Upjohn Co Nouveaux derives d5 de prostaglandines, leur procede de preparation et medicaments les contenant
FR2401921A1 (fr) * 1977-07-28 1979-03-30 Upjohn Co Derives de prostaglandines
FR2401920A1 (fr) * 1977-07-28 1979-03-30 Upjohn Co Derives de prostaglandines
EP0001270A1 (de) * 1977-09-27 1979-04-04 Hoechst Aktiengesellschaft Neue Prostacyclin-Analoga, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Behandlung von Herzkreislauf-Krankheiten
EP0005768A1 (en) * 1978-05-17 1979-12-12 The Wellcome Foundation Limited Pharmaceutical formulations containing prostaglandin compounds and method for their preparation
FR2425856A1 (fr) * 1978-05-17 1979-12-14 Wellcome Found Medicament a base de prostaglandines
EP0013955A1 (de) * 1979-01-25 1980-08-06 Hoechst Aktiengesellschaft Neue Analoga von Prostacyclin, deren Zwischenprodukte, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
EP0052204A1 (en) * 1980-11-13 1982-05-26 American Cyanamid Company Prostacyclin analogs of the 1 series and related analogs
FR2513639A1 (fr) * 1981-09-25 1983-04-01 Squibb & Sons Inc Nouvelles prostacyclines dioxatricycliques utiles comme medicaments cardio-vasculaires et produits nouveaux utiles comme intermediaires pour leur synthese
EP0084775A1 (de) * 1982-01-21 1983-08-03 MERCK PATENT GmbH 13-Thia-Prostacycline
WO2013024051A1 (en) * 2011-08-12 2013-02-21 Ascendis Pharma A/S Sustained release composition of prostacyclin
US9872864B2 (en) 2011-08-12 2018-01-23 Ascendis Pharma A/S Sustained release composition of prostacyclin
CN116621852A (zh) * 2023-04-21 2023-08-22 大连理工大学 基于内过氧化物的抗凝剂及应用

Also Published As

Publication number Publication date
FR2351112B1 (enrdf_load_stackoverflow) 1981-05-29

Similar Documents

Publication Publication Date Title
FR2351112A1 (fr) Derive de prostaglandine et medicament contenant ce derive
YU169584A (en) Process for making derivatives of 2-amino-5-hydroxi-4-methylpyrimidine
DE69311361D1 (de) Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten
SE7413349L (enrdf_load_stackoverflow)
NO150836C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (dl)-16-fenoksy- og 16-substituerte fenoksy-9-keto-prostatriensyrederivater
SE8904354D0 (sv) A pharmaceutical composition
MX6834E (es) Procedimiento para preparar compuestos analogos de la prostaciclina
ES426040A1 (es) Procedimiento de preparacion de esteres cicloalquil-alqui- licos de acidos que tienen el esqueleto del eburnano.
FR1066259A (fr) Procédé de préparation d'acides alpha-oméga-dibasiques ou de leurs dérivés
ES434827A1 (es) Procedimiento para la preparacion de derivados aminicos de los azidofenoles.
FR976783A (fr) Procédé de préparation d'alpha-glycols et de leurs dérivés
PT71891A (en) Process for the preparation of new 16-methoxy-16-methyl-prostaglandin e1 derivatives useful as gastroprotective agents
FR1028758A (fr) Perfectionnements apportés aux procédés de préparation d'une composition de vitamines
FR1017759A (fr) Procédé de préparation de dérivés de la phénothiazine
ES399726A1 (es) Procedimiento para la preparacion de compuestos para ali- viar sintomas de la enfermedad de parkinson.
FR1011680A (fr) Perfectionnements apportés aux procédés de fabrication de l'alpha-chlorométhylnaphtalène, notamment en vue de la préparation de l'acide alpha-naphtylacétique par synthèse
FR1121001A (fr) Perfectionnements à la préparation de dérivés sulfonés
FR1060362A (fr) Procédé de préparation de la semicarbazone de l'adrénochrome
FR1068766A (fr) Procédé de préparation de l'hormone circulatoire kallikréine
FR1015211A (fr) Perfectionnements apportés aux procédés pour la préparation de composés de streptomycine
FR1164152A (fr) Procédé pour la préparation d'esters bis-choliniques des acides dicarboxyliques, et de leurs dérivés
FR64604E (fr) Procédé pour la préparation du citrate ferreux de calcium
FR1056534A (fr) Procédé pour la préparation de dérivés de l'imidazol